7 hours ago
1
georgeclerk
Shares of Inovio Pharmaceuticals (NASDAQ:INO) gained ~4% in the morning hours on Tuesday after Piper Sandler initiated the DNA medicines developer with an Overweight recommendation, citing a potential FDA approval for its lead asset INO-3107 next year.
Analyst Edward Tenthoff’s
English (US) ·